Chimeron Bio & George Mason NCBID partner on COVID-19 vaccine using ChaESARTM technology
Collaboration will test pre-clinical efficacy and safety of vaccine pipeline including COVID-19 and other coronavirusesCredit: Chimeron Bio PHILADELPHIA,Pa & FAIRFAX, ...